Supreme Court’s looming mifepristone decision leaves abortion rights in spotlight

The Supreme Court’s expected decision this summer on whether to restrict access to medication abortion promises to keep the issue front and center of the 2024 election.

Justices will hear a case weighing federal approval of the common abortion pill mifepristone, with a likely ruling in June — five months before voters decide who will go to the White House and Congress, and almost exactly two years after the high court overturned the constitutional right to an abortion.

Both parties are now gearing up for one of the Supreme Court’s first abortion cases since reversing Roe v. Wade, a legal sea change that has galvanized voters toward the Democratic Party and bedeviled Republicans at the ballot box and the campaign trail.